Selected research
Industry Growth & Trends
Global Metronidazole Tablet Industry Growth and Trends Forecast to 2032
Market perspective
The global Metronidazole Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Metronidazole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Metronidazole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metronidazole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metronidazole Tablet include Yichang Changjiang Pharmaceutical, Wuyao Pharmaceutical, Zhongan Pharmaceutical, Tongji Pharmaceutical, Yinhe Aarti Pharmaceutical, Saikang Pharmaceutical, Hongda Pharmaceutical, Hongyuan Pharmaceutical and Unichem Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Metronidazole Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Metronidazole Tablet market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metronidazole Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metronidazole Tablet.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Metronidazole Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Metronidazole Tablet Market by Company
Yichang Changjiang Pharmaceutical
Wuyao Pharmaceutical
Zhongan Pharmaceutical
Tongji Pharmaceutical
Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Hongda Pharmaceutical
Hongyuan Pharmaceutical
Unichem Laboratories
Topsun Pharmaceutical
Manav Drugs
CordenPharma Farchemia
API Polpharma
Aarti Drugs
Aarey Drugs & Pharmaceuticals
Metronidazole Tablet Segment by Type
Glyoxal Process
Ethidene Diamine Process
Others
Metronidazole Tablet Segment by Application
Hospital
Clinic
Other
Metronidazole Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metronidazole Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metronidazole Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metronidazole Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metronidazole Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Metronidazole Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glyoxal Process
- Ethidene Diamine Process
- Others
Applications
- Hospital
- Clinic
- Other
Companies covered
- Yichang Changjiang Pharmaceutical
- Wuyao Pharmaceutical
- Zhongan Pharmaceutical
- Tongji Pharmaceutical
- Yinhe Aarti Pharmaceutical
- Saikang Pharmaceutical
- Hongda Pharmaceutical
- Hongyuan Pharmaceutical
- Unichem Laboratories
- Topsun Pharmaceutical
- Manav Drugs
- CordenPharma Farchemia
- API Polpharma
- Aarti Drugs
- Aarey Drugs & Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Metronidazole Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Metronidazole Tablet Sales Estimates and Forecasts (2021-2032)
- 1.3 Metronidazole Tablet Market by Type
- 1.3.1 Glyoxal Process
- 1.3.2 Ethidene Diamine Process
- 1.3.3 Others
- 1.4 Global Metronidazole Tablet Market Size by Type
- 1.4.1 Global Metronidazole Tablet Market Size Overview by Type (2021-2032)
- 1.4.2 Global Metronidazole Tablet Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Metronidazole Tablet Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Metronidazole Tablet Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Metronidazole Tablet Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Metronidazole Tablet Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Metronidazole Tablet Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Metronidazole Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Metronidazole Tablet Industry Trends
- 2.2 Metronidazole Tablet Industry Drivers
- 2.3 Metronidazole Tablet Industry Opportunities and Challenges
- 2.4 Metronidazole Tablet Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Metronidazole Tablet Revenue (2021-2026)
- 3.2 Global Top Players by Metronidazole Tablet Sales (2021-2026)
- 3.3 Global Top Players by Metronidazole Tablet Price (2021-2026)
- 3.4 Global Metronidazole Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metronidazole Tablet Major Company Production Sites & Headquarters
- 3.6 Global Metronidazole Tablet Company, Product Type & Application
- 3.7 Global Metronidazole Tablet Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metronidazole Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metronidazole Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Metronidazole Tablet Tier 1, Tier 2, and Tier 3
4 Metronidazole Tablet Regional Status and Outlook
- 4.1 Global Metronidazole Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Metronidazole Tablet Historic Market Size by Region
- 4.2.1 Global Metronidazole Tablet Sales in Volume by Region (2021-2026)
- 4.2.2 Global Metronidazole Tablet Sales in Value by Region (2021-2026)
- 4.2.3 Global Metronidazole Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Metronidazole Tablet Forecasted Market Size by Region
- 4.3.1 Global Metronidazole Tablet Sales in Volume by Region (2027-2032)
- 4.3.2 Global Metronidazole Tablet Sales in Value by Region (2027-2032)
- 4.3.3 Global Metronidazole Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metronidazole Tablet by Application
- 5.1 Metronidazole Tablet Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Metronidazole Tablet Market Size by Application
- 5.2.1 Global Metronidazole Tablet Market Size Overview by Application (2021-2032)
- 5.2.2 Global Metronidazole Tablet Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Metronidazole Tablet Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Metronidazole Tablet Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Metronidazole Tablet Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Metronidazole Tablet Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Metronidazole Tablet Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Metronidazole Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yichang Changjiang Pharmaceutical
- 6.1.1 Yichang Changjiang Pharmaceutical Company Information
- 6.1.2 Yichang Changjiang Pharmaceutical Business Overview
- 6.1.3 Yichang Changjiang Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yichang Changjiang Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.1.5 Yichang Changjiang Pharmaceutical Recent Developments
- 6.2 Wuyao Pharmaceutical
- 6.2.1 Wuyao Pharmaceutical Company Information
- 6.2.2 Wuyao Pharmaceutical Business Overview
- 6.2.3 Wuyao Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Wuyao Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.2.5 Wuyao Pharmaceutical Recent Developments
- 6.3 Zhongan Pharmaceutical
- 6.3.1 Zhongan Pharmaceutical Company Information
- 6.3.2 Zhongan Pharmaceutical Business Overview
- 6.3.3 Zhongan Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Zhongan Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.3.5 Zhongan Pharmaceutical Recent Developments
- 6.4 Tongji Pharmaceutical
- 6.4.1 Tongji Pharmaceutical Company Information
- 6.4.2 Tongji Pharmaceutical Business Overview
- 6.4.3 Tongji Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Tongji Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.4.5 Tongji Pharmaceutical Recent Developments
- 6.5 Yinhe Aarti Pharmaceutical
- 6.5.1 Yinhe Aarti Pharmaceutical Company Information
- 6.5.2 Yinhe Aarti Pharmaceutical Business Overview
- 6.5.3 Yinhe Aarti Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Yinhe Aarti Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.5.5 Yinhe Aarti Pharmaceutical Recent Developments
- 6.6 Saikang Pharmaceutical
- 6.6.1 Saikang Pharmaceutical Company Information
- 6.6.2 Saikang Pharmaceutical Business Overview
- 6.6.3 Saikang Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Saikang Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.6.5 Saikang Pharmaceutical Recent Developments
- 6.7 Hongda Pharmaceutical
- 6.7.1 Hongda Pharmaceutical Company Information
- 6.7.2 Hongda Pharmaceutical Business Overview
- 6.7.3 Hongda Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Hongda Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.7.5 Hongda Pharmaceutical Recent Developments
- 6.8 Hongyuan Pharmaceutical
- 6.8.1 Hongyuan Pharmaceutical Company Information
- 6.8.2 Hongyuan Pharmaceutical Business Overview
- 6.8.3 Hongyuan Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Hongyuan Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.8.5 Hongyuan Pharmaceutical Recent Developments
- 6.9 Unichem Laboratories
- 6.9.1 Unichem Laboratories Company Information
- 6.9.2 Unichem Laboratories Business Overview
- 6.9.3 Unichem Laboratories Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Unichem Laboratories Metronidazole Tablet Product Portfolio
- 6.9.5 Unichem Laboratories Recent Developments
- 6.10 Topsun Pharmaceutical
- 6.10.1 Topsun Pharmaceutical Company Information
- 6.10.2 Topsun Pharmaceutical Business Overview
- 6.10.3 Topsun Pharmaceutical Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Topsun Pharmaceutical Metronidazole Tablet Product Portfolio
- 6.10.5 Topsun Pharmaceutical Recent Developments
- 6.11 Manav Drugs
- 6.11.1 Manav Drugs Company Information
- 6.11.2 Manav Drugs Business Overview
- 6.11.3 Manav Drugs Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Manav Drugs Metronidazole Tablet Product Portfolio
- 6.11.5 Manav Drugs Recent Developments
- 6.12 CordenPharma Farchemia
- 6.12.1 CordenPharma Farchemia Company Information
- 6.12.2 CordenPharma Farchemia Business Overview
- 6.12.3 CordenPharma Farchemia Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 CordenPharma Farchemia Metronidazole Tablet Product Portfolio
- 6.12.5 CordenPharma Farchemia Recent Developments
- 6.13 API Polpharma
- 6.13.1 API Polpharma Company Information
- 6.13.2 API Polpharma Business Overview
- 6.13.3 API Polpharma Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 API Polpharma Metronidazole Tablet Product Portfolio
- 6.13.5 API Polpharma Recent Developments
- 6.14 Aarti Drugs
- 6.14.1 Aarti Drugs Company Information
- 6.14.2 Aarti Drugs Business Overview
- 6.14.3 Aarti Drugs Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Aarti Drugs Metronidazole Tablet Product Portfolio
- 6.14.5 Aarti Drugs Recent Developments
- 6.15 Aarey Drugs & Pharmaceuticals
- 6.15.1 Aarey Drugs & Pharmaceuticals Company Information
- 6.15.2 Aarey Drugs & Pharmaceuticals Business Overview
- 6.15.3 Aarey Drugs & Pharmaceuticals Metronidazole Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Aarey Drugs & Pharmaceuticals Metronidazole Tablet Product Portfolio
- 6.15.5 Aarey Drugs & Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Metronidazole Tablet Sales by Country
- 7.1.1 North America Metronidazole Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Metronidazole Tablet Sales by Country (2021-2026)
- 7.1.3 North America Metronidazole Tablet Sales Forecast by Country (2027-2032)
- 7.2 North America Metronidazole Tablet Market Size by Country
- 7.2.1 North America Metronidazole Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Metronidazole Tablet Market Size by Country (2021-2026)
- 7.2.3 North America Metronidazole Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Metronidazole Tablet Sales by Country
- 8.1.1 Europe Metronidazole Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Metronidazole Tablet Sales by Country (2021-2026)
- 8.1.3 Europe Metronidazole Tablet Sales Forecast by Country (2027-2032)
- 8.2 Europe Metronidazole Tablet Market Size by Country
- 8.2.1 Europe Metronidazole Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Metronidazole Tablet Market Size by Country (2021-2026)
- 8.2.3 Europe Metronidazole Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Metronidazole Tablet Sales by Country
- 9.1.1 Asia-Pacific Metronidazole Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Metronidazole Tablet Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Metronidazole Tablet Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Metronidazole Tablet Market Size by Country
- 9.2.1 Asia-Pacific Metronidazole Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Metronidazole Tablet Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Metronidazole Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Metronidazole Tablet Sales by Country
- 10.1.1 South America Metronidazole Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Metronidazole Tablet Sales by Country (2021-2026)
- 10.1.3 South America Metronidazole Tablet Sales Forecast by Country (2027-2032)
- 10.2 South America Metronidazole Tablet Market Size by Country
- 10.2.1 South America Metronidazole Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Metronidazole Tablet Market Size by Country (2021-2026)
- 10.2.3 South America Metronidazole Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Metronidazole Tablet Sales by Country
- 11.1.1 Middle East and Africa Metronidazole Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Metronidazole Tablet Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Metronidazole Tablet Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Metronidazole Tablet Market Size by Country
- 11.2.1 Middle East and Africa Metronidazole Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Metronidazole Tablet Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Metronidazole Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Metronidazole Tablet Value Chain Analysis
- 12.1.1 Metronidazole Tablet Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Metronidazole Tablet Production Mode & Process
- 12.2 Metronidazole Tablet Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Metronidazole Tablet Distributors
- 12.2.3 Metronidazole Tablet Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst